BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Leads Biolabs Doses First Patient In Phase II Trial Of PD L1 4 1BB Bispecific Antibody For Esophageal Cancer

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) announced on March 6, 2026 that the first patient has bee...

March 10, 2026 | News

China Approves Sciwind Ecnoglutide Injection For Chronic Weight Management

Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabo...

March 09, 2026 | News

Insilico Medicine AI Discovered CKD Anemia Drug ISM4808 Enters Phase I Clinical Trial

Insilico Medicine (Insilico Medicine, HKEX: 03696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), announced th...

March 09, 2026 | News

Sino Biological Launches 2026 To 2027 Influenza Vaccine Strain Antigens Following WHO Recommendations

The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine composition, highlighti...

March 06, 2026 | News

Akeso Reports Durable Long Term Survival Benefit Of Cadonilimab In Advanced Cervical Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the latest long-term survival analysis data from the China pivotal registrational Phase II ...

March 06, 2026 | Report

Antengene Grants UCB Global Rights To Develop And Commercialise ATG 201 Bispecific T Cell Engager

Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, t...

March 05, 2026 | News

XellSmart Secures Fourth Dual US And China Regulatory Clearance For iPSC Derived Cell Therapy In Multiple System Atrophy

XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for P...

March 04, 2026 | News

XtalPi And ReviR Dose First Participant In Phase One Trial Of RTX 117 For Rare Neurological Disorders

RTX-117 is an investigational small molecule designed to modulate the Integrated Stress Response (ISR) pathway, with the goal of restoring protein transl...

March 04, 2026 | News

Hua Medicine Secures First Glucokinase Activator Approval Outside Mainland China In Hong Kong

First glucokinase-activator (GKA) approval outside mainland China Approval supports a differentiated approach to Type 2 diabetes (T2D) ma...

March 04, 2026 | News

Innovent Secures China Approval For Jaypirca In Previously Treated CLL And SLL

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...

March 03, 2026 | News

SystImmune And Bristol Myers Squibb Report Dual PFS And OS Success For Iza Bren In Phase III TNBC Trial

Izalontamab brengitecan (Iza-bren) met its dual primary endpoints of progression free survival (“PFS”) and overall survival (“OS”...

March 02, 2026 | News

WuXi XDC And Earendil Labs Forge Strategic Alliance To Advance Next Generation AI Designed ADCs

WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializin...

March 02, 2026 | News

Sanyou Bio Completes Strategic Equity Restructuring With Liferiver Biotech And Yanghe Investment

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio"), a biotech company powered by super-trillion-molecule libraries and AI-driven technologies,&n...

February 26, 2026 | News

Antengene And Junshi Biosciences Enter Clinical Collaboration To Advance ATG 037 And JS207 Combination In Solid Tumors

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, ...

February 26, 2026 | News

Stay Connected